Elicio Therapeutics, Inc.
ELTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $62,235 | $42,169 | $18,259 | $18,848 |
| - Cash | $17,618 | $12,894 | $6,156 | $9,279 |
| + Debt | $26,040 | $6,917 | $7,482 | $11,797 |
| Enterprise Value | $70,657 | $36,192 | $19,585 | $21,366 |
| Revenue | $0 | $0 | $0 | $28,312 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$1,178 | -$1,170 | -$1,057 | $27,078 |
| % Margin | – | – | – | 95.6% |
| EBITDA | -$50,265 | -$32,966 | -$23,554 | -$51,925 |
| % Margin | – | – | – | -183.4% |
| Net Income | -$51,898 | -$35,195 | -$28,208 | -$26,401 |
| % Margin | – | – | – | -93.2% |
| EPS Diluted | -4.25 | -6.96 | -9.1 | -19.32 |
| % Growth | 38.9% | 23.5% | 52.9% | – |
| Operating Cash Flow | -$37,068 | -$32,694 | -$22,179 | -$23,939 |
| Capital Expenditures | -$87 | -$66 | -$654 | -$525 |
| Free Cash Flow | -$37,155 | -$32,760 | -$22,833 | -$24,464 |